Search Results - "Hsia, C"

An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure by HSIA, Connie C. W, HYDE, Dallas M, OCHS, Matthias, WEIBEL, Ewald R

Get full text

Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair by Shook, Brett A, Wasko, Renee R, Rivera-Gonzalez, Guillermo C, Salazar-Gatzimas, Emilio, López-Giráldez, Francesc, Dash, Biraja C, Muñoz-Rojas, Andrés R, Aultman, Krystal D, Zwick, Rachel K, Lei, Vivian, Arbiser, Jack L, Miller-Jensen, Kathryn, Clark, Damon A, Hsia, Henry C, Horsley, Valerie

“…During tissue repair, myofibroblasts produce extracellular matrix (ECM) molecules for tissue resilience and strength. Altered ECM deposition can lead to tissue…”
Get full text

Single cell transcriptomic landscape of diabetic foot ulcers by Theocharidis, Georgios, Thomas, Beena E., Sarkar, Debasree, Mumme, Hope L., Pilcher, William J. R., Dwivedi, Bhakti, Sandoval-Schaefer, Teresa, Sîrbulescu, Ruxandra F., Kafanas, Antonios, Mezghani, Ikram, Wang, Peng, Lobao, Antonio, Vlachos, Ioannis S., Dash, Biraja, Hsia, Henry C., Horsley, Valerie, Bhasin, Swati S., Veves, Aristidis, Bhasin, Manoj

“…Diabetic foot ulceration (DFU) is a devastating complication of diabetes whose pathogenesis remains incompletely understood. Here, we profile 174,962 single…”
Get full text

Comparative analysis of the mechanical signals in lung development and compensatory growth by Hsia, Connie C. W.

“…This review compares the manner in which physical stress imposed on the parenchyma, vasculature and thorax and the thoraco-pulmonary interactions, drive both…”
Get full text

Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough by Ruhl, Cody R., Pasko, Breanna L., Khan, Haaris S., Kindt, Lexy M., Stamm, Chelsea E., Franco, Luis H., Hsia, Connie C., Zhou, Min, Davis, Colton R., Qin, Tian, Gautron, Laurent, Burton, Michael D., Mejia, Galo L., Naik, Dhananjay K., Dussor, Gregory, Price, Theodore J., Shiloh, Michael U.

“…Pulmonary tuberculosis, a disease caused by Mycobacterium tuberculosis (Mtb), manifests with a persistent cough as both a primary symptom and mechanism of…”
Get full text

The potential and limitations of induced pluripotent stem cells to achieve wound healing by Gorecka, Jolanta, Kostiuk, Valentyna, Fereydooni, Arash, Gonzalez, Luis, Luo, Jiesi, Dash, Biraja, Isaji, Toshihiko, Ono, Shun, Liu, Shirley, Lee, Shin Rong, Xu, Jianbiao, Liu, Jia, Taniguchi, Ryosuke, Yastula, Bogdan, Hsia, Henry C, Qyang, Yibing, Dardik, Alan

“…Wound healing is the physiologic response to a disruption in normal skin architecture and requires both spatial and temporal coordination of multiple cell…”
Get full text

Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells by Desai, Vivek D, Hsia, Henry C, Schwarzbauer, Jean E

“…Unregulated activity of myofibroblasts, highly contractile cells that deposit abundant extracellular matrix (ECM), leads to fibrosis. To study the modulation…”
Get full text

The role of ciliary trafficking in Hedgehog receptor signaling by Kim, Jynho, Hsia, Elaine Y C, Brigui, Amira, Plessis, Anne, Beachy, Philip A, Zheng, Xiaoyan

“…Defects in the biogenesis of or transport through primary cilia affect Hedgehog protein signaling, and many Hedgehog pathway components traffic through or…”
Get more information

Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives by Iyer, Roshni, Hsia, Connie C W, Nguyen, Kytai T

“…Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted delivery of therapeutic molecules to the lung. Various types of…”
Get more information

The Efficacy and Safety of Fostamatinib in Elderly Patients with Immune Thrombocytopenia: A Single-Center, Real-World Case Series by Liu, Jessica, Hsia, Cyrus C.

“…Fostamatinib is a small molecule spleen tyrosine kinase (Syk) inhibitor that was approved for the treatment of adult patients with immune thrombocytopenia…”
Get full text

Lung protection by inhalation of exogenous solubilized extracellular matrix by Wu, Jinglei, Ravikumar, Priya, Nguyen, Kytai T, Hsia, Connie C W, Hong, Yi

“…Decellularized extracellular matrix (ECM) contains complex tissue-specific components that work in concert to promote tissue repair and constructive remodeling…”
Get full text

Characterization of Mg,Al-hydrotalcite conversion film on Mg alloy and Cl− and CO32- anion-exchangeability of the film in a corrosive environment by LIN, J, HSIA, C, UAN, J

Get full text

Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial by Baker, Joshua F, Ostergaard, Mikkel, Emery, Paul, Hsia, Elizabeth C, Lu, Jiandong, Baker, Daniel G, Conaghan, Philip G

“…To determine if early MRI measures predict X-ray progression at 1 and 2 years in a large RA trial cohort. This study included 256 methotrexate (MTX)-naïve RA…”
Get more information

Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population‐Based Matched Cohort Study by Chen, C.‐Y., Liu, C.‐J., Feng, J.‐Y., Loong, C.‐C., Liu, C., Hsia, C.‐Y., Hu, L.‐Y., Lin, N.‐C., Hu, Y.‐W., Yeh, C.‐M., Chen, T.‐J., Yang, C.‐C.

“…Morbidity and mortality from tuberculosis (TB) are high in Taiwan. We conducted a nationwide population‐based matched cohort study using data retrieved from…”
Get full text

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis by Husni, M Elaine, Deodhar, Atul, Schwartzman, Sergio, Chakravarty, Soumya D, Hsia, Elizabeth C, Leu, Jocelyn H, Zhou, Yiying, Lo, Kim H, Kavanaugh, Arthur

“…Intravenous (IV) golimumab, a TNFi, is approved for treating rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). We analyzed…”
Get full text

Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis by Rahman, Proton, Mease, Philip J, Helliwell, Philip S, Deodhar, Atul, Gossec, Laure, Kavanaugh, Arthur, Kollmeier, Alexa P, Hsia, Elizabeth C, Zhou, Bei, Lin, Xiwu, Shawi, May, Karyekar, Chetan S, Han, Chenglong

“…The interleukin-23p19-subunit inhibitor guselkumab effectively treats signs and symptoms of psoriatic arthritis (PsA). We evaluated the effect of guselkumab on…”
Get full text

How much is there really? Why stereology is essential in lung morphometry by Weibel, Ewald R, Hsia, Connie C. W, Ochs, Matthias

“…1 Institute of Anatomy, University of Bern, Bern, Switzerland; and 2 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas,…”
Get full text

Hedgehog mediated degradation of Ihog adhesion proteins modulates cell segregation in Drosophila wing imaginal discs by Hsia, Elaine Y. C., Zhang, Ya, Tran, Hai Son, Lim, Agnes, Chou, Ya-Hui, Lan, Ganhui, Beachy, Philip A., Zheng, Xiaoyan

“…The Drosophila Hedgehog receptor functions to regulate the essential downstream pathway component, Smoothened, and to limit the range of signaling by…”
Get full text

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial by Smolen, Josef S, Prof, Kay, Jonathan, MD, Doyle, Mittie K, MD, Landewé, Robert, MD, Matteson, Eric L, Prof, Wollenhaupt, Jürgen, Prof, Gaylis, Norman, MD, Murphy, Frederick T, MD, Neal, Jeffrey S, MD, Zhou, Yiying, PhD, Visvanathan, Sudha, PhD, Hsia, Elizabeth C, MD, Rahman, Mahboob U, MD

“…Summary Background Tumour necrosis factor α (TNFα) inhibitors are frequently used to treat rheumatoid arthritis, but whether use of a different TNFα inhibitor…”
Get full text

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer by Scagliotti, G.V., Bondarenko, I., Blackhall, F., Barlesi, F., Hsia, T.-C., Jassem, J., Milanowski, J., Popat, S., Sanchez-Torres, J.M., Novello, S., Benner, R.J., Green, S., Molpus, K., Soria, J.-C., Shepherd, F.A.

“…The addition of figitumumab to erlotinib did not improve outcomes in patients with advanced, pretreated, nonadenocarcinoma NSCLC. Figitumumab (CP-751,871) is a…”
Get full text